Sign in
CompletedNo phase

Investigation of Serum Sclerostin Levels in Patients With Erectile Dysfunction

Key facts

Who runs it
Medipol University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
97 people enrolled
Started
2 Jan 2023
Ended
2 Jan 2024
Type of study
Observational, 2 groups
Record updated
28 October 2026

Who can take part

Age
18 years to 65 years
Sex
Men only
Healthy volunteers
Can take part

The registry criteria, word for word

Show the criterionShow less

Who cannot take part

  • -

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective, observational case-control study aims to investigate the potential role of sclerostin-a molecule associated with cardiovascular pathologies-in the vascular pathogenesis of erectile dysfunction (ED). The study compares peripheral venous sclerostin levels between men diagnosed with ED and healthy volunteers. Additionally, it evaluates cavernosal blood sclerostin levels within the ED group to explore localized vascular changes.

The 2 groups in the trial

  • Case Group

    Patients diagnosed with erectile dysfunction who undergo the Combined Intracavernosal Injection and Stimulation Test (KİST) and provide peripheral and cavernosal blood samples.

  • Control Group

    Healthy male volunteers without erectile dysfunction who provide only peripheral venous blood samples.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
28 October 2026